Silence Therapeutics PLC (ADR) - SLN - stock price prediction, stock price target, analyst ratings from 7 analysts

Silence Therapeutics PLC (ADR) has a share price target of US$ 29, revenue growth forecast of 494.6%, and profit growth estimate of 24.8% for FY26, based on top 7 analyst calls.